SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,154,000 | +47.2% | 12,679 | 0.0% | 0.72% | +17.1% |
Q1 2020 | $1,463,000 | -32.5% | 12,679 | -68.7% | 0.61% | -34.3% |
Q4 2017 | $2,166,000 | -1.7% | 40,495 | 0.0% | 0.94% | -5.0% |
Q3 2017 | $2,203,000 | +50.2% | 40,495 | +42.8% | 0.98% | +47.3% |
Q2 2017 | $1,467,000 | -27.7% | 28,351 | -12.2% | 0.67% | -17.3% |
Q1 2017 | $2,029,000 | +78.0% | 32,284 | -9.0% | 0.81% | +50.5% |
Q4 2014 | $1,140,000 | -13.6% | 35,489 | 0.0% | 0.54% | +26750.0% |
Q3 2014 | $1,319,000 | -2.8% | 35,489 | 0.0% | 0.00% | -99.8% |
Q2 2014 | $1,357,000 | – | 35,489 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |